Globeflex Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Globeflex Capital's TVTX Position: Q3 2026 in Review
Globeflex Capital opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 36 shares worth $2.12K. The stake represents ﹤0.01% of the portfolio and ranks #377 among its holdings. This is a return to the name: Globeflex Capital previously reported a position in TVTX as recently as Q2 2020.
Globeflex Capital first reported a position in TVTX in Q3 2015 and has held it in 4 quarters since. The position peaked at $500K in Q2 2020. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Globeflex Capital held 36 shares of Travere Therapeutics worth $2.12K as of Q3 2026.
- Travere Therapeutics was a new Globeflex Capital position in Q3 2026.
- Travere Therapeutics made up ﹤0.01% of Globeflex Capital's portfolio in Q3 2026, its #377 holding.
- Globeflex Capital first reported a position in Travere Therapeutics in Q3 2015 and has held it in 4 quarters since.
- Globeflex Capital's Travere Therapeutics position peaked at $500K in Q2 2020.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Globeflex Capital's 13F filing for Q3 2026, filed 16 Nov 2026.